[Case of laparoscopic cholecystectomy in a patient with glucose-6-dehydrogenase deficiency]

Rina Wada1, Hirofumi Hino, Yumi Ando

  • 1Department of Anesthesiology, St. Marianna University School of Medicine, Kawasaki, Japan.

Masui. the Japanese Journal of Anesthesiology
|February 19, 2008
PubMed

Insights

Anesthesia management for glucose-6-phosphate dehydrogenase (G6PD) deficiency patients requires avoiding oxidant stress. This study found that midazolam, vecuronium, nitrous oxide, and sevoflurane provided safe anesthesia, preventing hemolysis in a G6PD-deficient child.

Area of Science:

  • Anesthesiology
  • Clinical Pharmacology
  • Genetics

Background:

  • Glucose-6-phosphate dehydrogenase (G6PD) deficiency is a genetic disorder.
  • Patients with G6PD deficiency are susceptible to acute hemolytic anemia.
  • Hemolysis can be triggered by oxidant drugs, infections, and surgical stress.

Observation:

  • A 5-year-old male with a history of hemolysis due to G6PD deficiency underwent laparoscopic cholecystectomy.
  • The patient had experienced hemolysis with infections and fava bean ingestion (favism).

Findings:

  • Anesthesia was induced using midazolam and vecuronium.
  • Maintenance involved nitrous oxide in oxygen and sevoflurane.
  • No hemolytic changes were observed during the perioperative period.
  • This anesthetic drug combination proved safe for the G6PD-deficient patient.

Implications:

  • Careful selection of anesthetic agents is crucial for G6PD-deficient patients.
  • Avoiding oxidant stress during anesthesia is paramount.
  • The study suggests specific anesthetic drugs can be safely used in G6PD deficiency.

Related Concept Videos